BridgeMD
New treatment option for Rotator Cuff Tear
Official title ISB With SSNB & ANB
ClinicalTrials.gov ID: NCT06878391
What this study is testing
- What it's testing
- This study is a prospective, randomized, double-blind trial comparing patients who underwent arthroscopic rotator cuff repair and received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with suprascapular nerve block and axillary nerve block (each with 10 ml of 0.75% ropivacaine) versus those who received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with placebo suprascapular and axillary nerve blocks (each with 10 ml of 0.9% saline). The study will compare subjective pain scores (VAS score) and patient satisfaction preoperatively and at 1, 3, 6, 12, 18, 24, 36, and 48 hours postoperatively.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- a definite rotator cuff tear that needed repair seen on preoperative magnetic resonancce imaging (MRI)
- acceptance of arthroscopic surgery including rotator cuff repair
- age same as or more than 20 years
- acceptance of preemptive regional block and PCA, and blood testing
You likely can't join if
- did not undergo arthroscopic rotator cuff repair
- stopped PCA before 48 hours postoperatively because of associated side effects
- a history of previous ipsilateral shoulder operation or fracture
- a concomitant neurologic disorder around the shoulder
- a failure of blood sampling including hemolysis, etc.
The study team makes the final eligibility decision.
Where it's taking place
- Chuncheon, Gangwon-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chuncheon, Gangwon-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.